General Partner Corporate Finance and CFO (based in Munich)
General Partner Corporate Finance and Chief Financial Officer (based in Munich) Stefan Fischer joined TVM Capital in 2000 and is General Partner Corporate Finance at TVM Capital in Munich. He has been responsible for the corporate finance side of the investment activities of the life science team for many years and was actively involved in numerous IPOs and trade sales of TVM Capital portfolio companies. Stefan Fischer made major contributions to the fundraising of TVM Life Sciences Ventures VII and is now promoted to Chief Financial Officer of the firm. Mr. Fischer is the Chairman of the Supervisory Board of pritidenta GmbH (Leinfelden-Echterdingen, Germany), the Vice-Chairman of the Supervisory Board of Direvo IBT GmbH (Cologne, Germany) and serves as a board observer to Biovertis AG (Vienna, Austria). Mr. Fischer holds overall responsibility for the finance operations of our Munich and Montreal offices as well as for our life science venture capital funds..
Mr. Fischer was actively involved in numerous IPOs of TVM Capital portfolio companies like Intercell, Jerini, Wilex, Newron and BioXell as well as in trade sales like and Arrow Therapeutics and Direvo Biotech. Prior to joining TVM Capital, Mr. Fischer spent three years as a consultant in the corporate finance department of KPMG Deutsche Treuhand-Gesellschaft, where he gained extensive experience in the valuation of enterprises, financial due diligence, corporate restructuring and auditing through national and international projects. Mr. Fischer earned a master degree in business administration at the University of Passau. His focus was Corporate Finance, Banking and IT. Furthermore, he specialised in Corporate Finance and Business Communication at the Helsinki School of Economics. He is a member of the Working Group Finance at BioDeutschland Association.